Company: KEQU
Filing Date: 2025-12-12
Form Type: 10-Q
Source: 0000055529-25-000054
Chunk: 46

Company: KEWAUNEE SCIENTIFIC CORP /DE/
Filing Date: 2025-12-12
Form: 10-Q
Item: Part I, Item 8
Chunk 46
---
2420252024(actual)(pro forma)(actual)(pro forma)Net sales$70,096 $66,933 $141,200 $132,381 Net earnings2,445 2,696 5,538 6,969 Net earnings per share attributable to Kewaunee Scientific Corporation stockholders:Basic$0.85 $0.94 $1.94 $2.44 Diluted$0.82 $0.91 $1.86 $2.35 

9

D. Revenue Recognition

The Company recognizes revenue when control of a good or service promised in a contract (i.e., performance obligation) is transferred to a customer. Control is obtained when a customer has the ability to direct the use of and obtain substantially all of the remaining benefits from that good or service. The majority of the Company's revenues are recognized over time as the customer receives control as the Company performs work under a contract. However, a portion of the Company's revenues are recognized at a point-in-time as control is transferred at a distinct point in time per the terms of a contract.Disaggregated RevenueA summary of net sales transferred to customers over time and at a point in time for the periods ended October 31, 2025 and October 31, 2024 is as follows (in thousands):Three Months Ended October 31, 2025October 31, 2024 DomesticInternationalTotalDomesticInternationalTotalOver Time$32,911 $14,872 $47,783 $35,123 $11,355 $46,478 Point in Time22,313 — 22,313 1,286 — 1,286 Total$55,224 $14,872 $70,096 $36,409 $11,355 $47,764 Six Months Ended October 31, 2025October 31, 2024 DomesticInternationalTotalDomesticInternationalTotalOver Time$65,624 $31,624 $97,248 $69,512 $24,225 $93,737 Point in Time43,952 — 43,952 2,420 — 2,420 Total$109,576 $31,624 $141,200 $71,932 $24,225 $96,157 Contract BalancesThe closing